XML 30 R118.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule I Schedule I - CONDENSED STATEMENT OF CASH FLOWS (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Financial Statements, Captions [Line Items]      
Cash flows from operating activities $ (109.4) $ 30.2 $ 63.0
Cash flows from investing activities      
Change in restricted cash 773.9 (680.5) (517.7)
Payments to acquire businesses, net of transaction costs and cash acquired (19.5) (37.9) (19.0)
Purchase of additional interests in subsidiaries 0 0 (75.4)
Purchase of Linq/Octavius from non-guarantor 0    
Proceeds paid for sale of assets 0    
Other (12.5) (5.5) (9.9)
Cash flows used in investing activities 64.8 (1,224.3) (1,006.3)
Cash flows from financing activities      
Issuance of common stock, net of fees 217.2 17.4 0
Other (14.7) (13.5) (22.0)
Transfer to affiliates 0 0 0
Cash flows from financing activities 651.1 1,472.6 811.5
Net increase/(decrease) in cash and cash equivalents 1,009.0 857.6 (82.4)
Cash and cash equivalents, beginning of period 1,757.5 891.2 971.1
Cash and cash equivalents, end of period 2,771.2 1,757.5 891.2
CEC (Parent Guarantor) [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Cash flows from operating activities 407.9 258.6 182.9
Cash flows from investing activities      
Change in restricted cash (50.5) 0 0
Payments to acquire businesses, net of transaction costs and cash acquired 0 0 (123.5)
Purchase of additional interests in subsidiaries (581.2) (232.5) 0
Purchase of Linq/Octavius from non-guarantor (80.7) 0 0
Proceeds paid for sale of assets (29.0) 0 0
Other (0.4) (0.8) 0
Cash flows used in investing activities (741.8) (233.3) (123.5)
Cash flows from financing activities      
Issuance of common stock, net of fees 217.2 17.4 0
Other 0 0 (1.7)
Transfer to affiliates 222.6 (39.2) (189.8)
Cash flows from financing activities 439.8 (21.8) (191.5)
Net increase/(decrease) in cash and cash equivalents 105.9 3.5 (132.1)
Cash and cash equivalents, beginning of period 7.4 3.9 136.0
Cash and cash equivalents, end of period $ 113.3 $ 7.4 $ 3.9